Better than SPIRIVA AND FORADIL?
NEW THERAPY FOR COPD CLAIMS TO BE SUPERIOR TO SPIRIVA AND FORADIL
Pearl Therapeutics, located in the U.S., announces that its new drug PT003, a combination bronchodilator, provides better bronchodilation than Spiriva and Foradil. PT003, still undergoing trials, uses a metered dose inhaler (MDI), and is proving to be safe and well-tolerated. Studies were conducted on individual with "moderate" to "very severe" COPD. For more information, visit:
see more at
http://www.pearltherapeutics.com/press-releases.php?press_number=1024
Tuesday, December 14, 2010
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment